Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Novel Targeted Liposomal Treatment for Tuberculosis


Technology Benefits

Targeted deliverySustained releaseDecreased side effects


Technology Application

mycobacterium infection treatment


Detailed Technology Description

Our inventorΓÇÖs have developed novel anti-TB liposomes that are capable of encapsulating common clinical anti-TB drugs and can be coated with TGF-╬▓1 siRNA. These multifunctional liposomes have proven to be stable under ambient conditions, display low cytotoxicity, and prolonged release in in vitro studies. This nanoparticle system address many of the issues with the current gold standard ofchemotherapeutic treatment and has the potential to significantly improve the treatment of tuberculosis.


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View